Treatment outcome of MDR pulmonary tuberculosis in a tertiary care hospital of Karachi, Pakistan

Danish Rao (Karachi, Pakistan), Danish Rao, Nisar Rao, Saifullah Baig, Nadeem Ahmed

Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Session: Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Session type: Thematic Poster Session
Number: 2701
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Danish Rao (Karachi, Pakistan), Danish Rao, Nisar Rao, Saifullah Baig, Nadeem Ahmed. Treatment outcome of MDR pulmonary tuberculosis in a tertiary care hospital of Karachi, Pakistan. Eur Respir J 2015; 46: Suppl. 59, 2701

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pattern of drug resistance in TB patients treated at DR TB unit in tertiary care public sector hospital in Karachi Pakistan
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016


Changing prevalence of MDR TB and XDR TB in a tertiary care hospital in India
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Study on drug sensitivity patterns in tuberculosis in tertiary care in Mumbai
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate?
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Sputum culture conversion among the first cohorts of MDR-TB patients managed in Nigeria at a tertiary care hospital
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Management of tuberculosis (TB) at a district general hospital: An audit of practice
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Factors associated with pulmonary tuberculosis treatment outcome in Kocaeli; Turkey
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Frequency of chronic pulmonary aspergillosis in patients treated for pulmonary tuberculosis at a tertiary care hospital in Karachi, Pakistan.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021


Prevalence of fluoroquinolone resistance in mycobacterium tuberculosis in a tertiary care hospital in India
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014


Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care unit
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014


The tale of two hospitals: Urban and suburban patients with tuberculosis and their outcomes
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014


Centralization of M/XDR-TB care in clinical reference centres in Portugal. Experience of a regional reference centre
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Out-patient MDR-TB care in Moldova
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India.
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019

Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


Prevalence of MDR TB and XDR TB in a tertiary care hospital in India
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008